Protein biomarkers that can identify Alzheimer's have been discovered. With a simple blood test, even the earliest stages of Alzheimer’s and Mild Cognitive Impairment may be reliably differentiated from controls. Working in collaboration with dementia centers in the US and Europe, our vision is to combine early diagnosis of Alzheimer's with presently available therapies and future disease-modifying therapies.
|
LATEST NEWS
November 3, 2009 Satoris Awarded Michael J. Fox Foundation Grant to Develop "Biological Fingerprint" for Parkinson's Disease
Research study will use Satoris proprietary antibody technology to measure over 500 distinct plasma proteins and attempt to identify a cellular signal for Parkinson's disease in blood. more > Upcoming Events
2/03/2010 - 2/05/2010
Cambridge Healthtech Institute's 17th International Molecular Medicine Tri-Conference 2010
San Francisco, CA, USA
www.tri-conference.com
New Publication
Multiplex Panels as Diagnostic Tools in Alzheimer’s Disease [Click Here for Abstract] |
